羅氏藥廠的下個金雞母-瀰漫性大型B細胞淋巴瘤的第3線藥物Columvi (anti-CD20XCD3 bispecific Ab)
Update: 2023-10-24
Description
難易度: *****
#Glofitamab#Columvi#Roche#羅氏藥廠#DLBCL#瀰漫性大型B細胞淋巴瘤#bispecificAb#雙特異性抗體#CD20XCD3#mosunetuzumab-axgb#epco’ritamab-bysp#ADC#CART#ORR#CompleteResponse#CytokineReleaseSyndrome
請我喝杯咖啡吧https://open.firstory.me/join/science-up
小額贊助支持本節目: https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1
留言告訴我你對這一集的想法: https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1/comments
Powered by Firstory Hosting
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel